A cross-institutional research group has revealed for the first time in the world that infants with symptomatic congenital cytomegalovirus (CMV) infection who were treated with a combination of immunoglobulin...
A two-week course of antiviral therapy with interferon beta-1b plus lopinavir-ritonavir and ribavirin, started within 7 days of showing COVID-19 symptoms, is safe and more effective at reducing the duration...
Cocrystal Pharma, Inc., a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced that it has entered into a license agreement with Kansas State University...
A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver...
A large, multi-center study refutes earlier suggestions that antiviral drugs for treating hepatitis C may lead to a higher recurrence of liver cancer.
Researchers at UT Southwestern Medical Center studied...
High doses of favipiravir extended survival in non-human primates infected with Ebola virus, according to a new study published this week in PLOS Medicine by Jeremie Guedj of INSERM, France, and colleagues.
Despite...
Herpes of the eye, or ocular herpes, is a recurring viral infection that’s usually caused by the herpes simplex virus-1 (HSV-1). This is the same virus that causes cold sores. Ocular herpes can also...
Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new regulator of the innate immune response–the immediate, natural immune response to foreign invaders. The...
Outbreaks of stomach flu or noroviral gastroenteritis can easily occur in crowded quarters like cruise ships, army barracks and schools, but a recent patent may lead to antiviral drugs to help travelers,...
Viruses have a way of taking over the headlines from time to time–in 2009 it was H1N1 influenza. A couple of years ago, Ebola dominated the airwaves and today, it is difficult to turn on the news...
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
